Jennifer Hathaway, NP
Nurse Practitioner · Castle Rock, CONPI 1467957555
Payments from drug & device makers
Across 73 payments — averaging $20.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$295
- AbbVie$187
- Medtronic$181
- Novo Nordisk$124
- Astellas Pharma US Inc$121
- Lilly USA, LLC$72
- plus $534 from 17 others
What the payments were for
- Food & beverage$1,50499%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $295 |
| AbbVie | 10 | $187 |
| Medtronic | 5 | $181 |
| Novo Nordisk | 8 | $124 |
| Astellas Pharma US Inc | 5 | $121 |
| Lilly USA, LLC | 4 | $72 |
| Pfizer | 3 | $69 |
| Edwards Lifesciences | 2 | $66 |
| Amgen | 3 | $66 |
| Bayer | 3 | $55 |
| Merck | 2 | $38 |
| Johnson & Johnson | 2 | $29 |
| Grifols USA, LLC | 1 | $28 |
| Viiv Healthcare Company | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| GSK | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Exeltis, USA Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Upsher-smith Laboratories LLC | 1 | $14 |
How this compares
$1,516 in reported general payments places this provider in the 85th percentile of 1,384 nurse practitioner providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 43 | $80,023 |
| EliquisApixaban | 23 | $34,670 |
| FarxigaDapagliflozin Propanediol | 12 | $18,959 |
| MounjaroTirzepatide | 12 | $15,078 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,505 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $4,376 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $4,304 |
| Levothyroxine Sodium | 193 | $1,773 |
| YuvafemEstradiol | 13 | $1,570 |
| Atorvastatin Calcium | 153 | $1,511 |
| SynthroidLevothyroxine Sodium | 26 | $1,490 |
| Gabapentin | 77 | $1,445 |
| Rosuvastatin Calcium | 77 | $1,409 |
| Estradiol | 24 | $1,100 |
| Estradiol (Twice Weekly)Estradiol | 11 | $1,096 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $124 | $80,02343 claims |
| PfizerEliquis | $69 | $34,67023 claims |
| AstraZenecaFarxiga | $295 | $18,95912 claims |
| Lilly USA, LLCMounjaro | $72 | $15,07812 claims |
| AbbVieSynthroid | $187 | $1,49026 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,384 nurse practitioner providers in Colorado.
Other nurse practitioner in Castle Rock
- Mary PeifferCastle Rock$5K
- Monica RabanalEvergreen$1.6M
- Deborah HinnenColorado Springs$388K
- Christina HansonLone Tree$381K
- Christina ProulxDenver$222K
- Kara HartPueblo$142K
- Amy SidorskiAurora$97K
- Lori WenzGrand Junction$54K
- Lisa KeithColorado Springs$52K
- Victoria SegroEnglewood$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.